Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9899165 | 1.00 | PTGES (0.47) | PTGESSCN10A | |
| SCHEMBL9947056 | 0.90 | PTGES (0.49) | PTGES | |
| SCHEMBL9946574 | 0.89 | PTGES (0.46) | PTGES | |
| SCHEMBL9899136 | 0.88 | POLB (0.44) | PTGES | |
| SCHEMBL9899139 | 0.88 | POLB (0.44) | PTGES | |
| SCHEMBL9944739 | 0.86 | RAB9A (0.45) | — | |
| SCHEMBL9946743 | 0.83 | PTGES (0.46) | PTGES | |
| SCHEMBL9946795 | 0.83 | PTGES (0.46) | PTGES | |
| SCHEMBL9899704 | 0.82 | PTGES (0.41) | PTGESSCN10A | |
| SCHEMBL9899702 | 0.82 | PTGES (0.41) | PTGESSCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674113-B2 | Compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20120149676-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149676-A1 | NOVEL COMPOUNDS | PTGS1, PTGER1, PTGES | PTGES 3/4885SCN10A 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.